Published on: 2025-07-01 | Written by:
In a groundbreaking achievement, scientists at the University of California, Los Angeles (UCLA) have successfully developed the first model of a miniature human lung containing a functional blood vessel network. This represents a major breakthrough in biomedical science and tissue engineering. Known as a lung organoid, this miniature organ closely mimics the structure and function of real human lung tissue and opens new doors in pulmonary disease research and drug testing.
Organoids are lab-grown miniature versions of organs created from human stem cells that simulate both the structure and function of the actual organ.
They are used to:
Study organ development at the genetic and cellular levels
Understand disease mechanisms in detail
Test the efficacy and toxicity of new drugs
Explore potential for tissue regeneration and transplantation
What makes this particular lung organoid exceptional is that it is the first of its kind to include a complete and functional vascular system, bringing it closer than ever to a real human lung.
The research team began with induced pluripotent stem cells (iPSCs) derived from human donors. Through a precise protocol, they guided these cells to develop into:
Lung tissue with tiny alveolar structures
A fine network of endothelial cells forming blood vessels
A 3D environment replicating the lung's architecture and biological behavior
Advanced bioprinting and cellular profiling techniques were used to simultaneously differentiate lung and vascular cells, achieving a level of integration not seen in previous models.
Integrating blood vessels is a crucial step toward building functional human organs. The vascular network allows for:
Gas exchange (oxygen and carbon dioxide), like in real lungs
Delivery of drugs and nutrients to test their real-time effects
Simulation of immune and inflammatory responses in lung tissue
Potential for future transplantation to treat diseases like pulmonary fibrosis or chronic obstructive pulmonary disease (COPD)
Accurate, cost-effective drug testing for chronic lung conditions
Studying the effects of respiratory viruses like influenza and COVID-19
Developing lab-grown lung tissue for treating respiratory failure
Designing personalized gene therapies using patient-specific organoids
The creation of the first miniature human lung with integrated blood vessels marks a revolution in organ engineering and drug research. It brings us one step closer to a long-standing dream in medicine: growing fully functional human organs in the lab. While clinical transplantation is still a future goal, this lung organoid serves as an ideal platform to understand human lung function like never before.